Aptiv Board Approves Versigent Spin-Off, Sets April 1 Distribution Date
APTV sits 53% above its 52-week low of $47.19.
Summary
Aptiv's Board of Directors has formally approved the spin-off of Versigent, setting a record date of March 17, 2026, and an effective distribution date of April 1, 2026. Shareholders will receive one Versigent share for every three Aptiv shares held. This approval provides the definitive terms for the separation, following recent SEC filings and news on March 4th and 5th that detailed Versigent's successful pricing of a $1.6 billion private offering of senior notes and securing credit facilities. The spin-off is a significant corporate restructuring aimed at allowing both entities to pursue independent strategies and potentially unlock shareholder value. Investors will now focus on the execution of the spin-off and the independent performance of both Aptiv and Versigent post-separation.
At the time of this announcement, APTV was trading at $72.21 on NYSE in the Technology sector, with a market capitalization of approximately $15.4B. The 52-week trading range was $47.19 to $88.93. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Reuters.